Puma Biotechnology

$10.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-1.79%) Today
$0.00 (0.00%) As of 4:09 PM EDT after-hours

Why Robinhood?

You can buy or sell PBYI and other stocks, options, ETFs, and crypto commission-free!

About PBYI

Puma Biotechnology Inc Common Stock, also called Puma Biotechnology, is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. Read More The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Employees
272
Headquarters
Los Angeles, California
Founded
2010
Market Cap
427.48M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.51M
High Today
$11.41
Low Today
$10.93
Open Price
$11.13
Volume
1.05M
52 Week High
$50.75
52 Week Low
$8.45

Collections

PBYI News

BenzingaAug 9

Mid-Morning Market Update: Markets Open Lower; Uber Misses Q2 Expectations

496
ReutersAug 9

Edited Transcript of PBYI earnings conference call or presentation 8-Aug-19 8:30pm GMT

107

PBYI Earnings

-$1.98
-$1.41
-$0.83
-$0.26
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, After Hours

Popular Stocks

More PBYI News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.